^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Target Selector™ NGS Lung Panel

    Company:
    Biocept
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    over2years
    Quest Diagnostics now offers Biocept’s liquid biopsy test for lung cancer, expanding its menu of advanced cancer diagnostics (Quest Diagnostics Press Release)
    "Physicians in the United States can now order the liquid biopsy-based Target Selector™ NGS Lung Panel test directly from Quest Diagnostics...Developed by Biocept, Inc...the lab-developed liquid biopsy test aids genomic profiling in patients with advanced non-small cell lung cancer (NSCLC), helping physicians identify potential targeted therapies and monitor the effectiveness of treatment...The Target Selector NGS Lung Panel contributes to better patient outcomes by providing physicians with direction on therapeutic options for those battling NSCLC."
    Licensing / partnership
    |
    Target Selector™ NGS Lung Panel